The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Evolution of the Cannabinoid and Terpene Content during the Growth of Cannabis sativa Plants from Different Chemotypes
Abstract
The evolution of major cannabinoids and terpenes during the growth of Cannabis sativa plants was studied. In this work, seven different plants were selected: three each from chemotypes I and III and one from chemotype II. Fifty clones of each mother plant were grown indoors under controlled conditions. Every week, three plants from each variety were cut and dried, and the leaves and flowers were analyzed separately. Eight major cannabinoids were analyzed via HPLC-DAD, and 28 terpenes were quantified using GC-FID and verified via GC-MS. The chemotypes of the plants, as defined by the tetrahydrocannabinolic acid/cannabidiolic acid (THCA/CBDA) ratio, were clear from the beginning and stable during growth. The concentrations of the major cannabinoids and terpenes were determined, and different patterns were found among the chemotypes. In particular, the plants from chemotypes II and III needed more time to reach peak production of THCA, CBDA, and monoterpenes. Differences in the cannabigerolic acid development among the different chemotypes and between monoterpene and sesquiterpene evolution patterns were also observed. Plants of different chemotypes were clearly differentiated by their terpene content, and characteristic terpenes of each chemotype were identified.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.
Russo, E. B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01238.x · Cited by 1,535
Synergy research: approaching a new generation of phytopharmaceuticals.
Wagner, H., & Ulrich-Merzenich, G. (2009) · Phytomedicine · doi:10.1016/j.phymed.2008.12.018 · Cited by 1,296
Chemical constituents of marijuana: The complex mixture of natural cannabinoids
ElSohly, M. A., & Slade, D. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.09.011 · Cited by 1,094
Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb
Izzo, A. A., Borrelli, F., Capasso, R., Di Marzo, V., & Mechoulam, R. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.07.006 · Cited by 820
Galve-Roperh, I., Sánchez, C., Cortés, M. L., del Pulgar, T. G., Izquierdo, M., & Guzmán, M. (2000) · Nature Medicine · doi:10.1038/73171 · Cited by 682
Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis
Rog, D. J., Nurmikko, T. J., Friede, T., & Young, C. A. (2005) · Neurology · doi:10.1212/01.wnl.0000176753.45410.8b · Cited by 679
History of Cannabis and Its Preparations in Saga, Science, and Sobriquet
Russo, E. B. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790144 · Cited by 621
Wade, D. T., Makela, P., Robson, P., House, H., & Bateman, C. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1082oa · Cited by 589
Chronic Administration of Cannabidiol to Healthy Volunteers and Epileptic Patients
Cunha, J. M., Carlini, E. A., Pereira, A. E., Ramos, O. L., Pimentel, C., Gagliardi, R., Sanvito, W. L., Lander, N., & Mechoulam, R. (2008) · Pharmacology · doi:10.1159/000137430 · Cited by 568
Jatoi, A., Windschitl, H. E., Loprinzi, C. L., Sloan, J. A., Dakhil, S. R., Mailliard, J. A., Pundaleeka, S., Kardinal, C. G., Fitch, T. R., Krook, J. E., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.2.567 · Cited by 543
Cannabidiol: An Overview of Some Pharmacological Aspects
Mechoulam, R., Parker, L. A., & Gallily, R. (2002) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.2002.tb05998.x · Cited by 508
Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS
Beal, J. E., Olson, R., Laubenstein, L., Morales, J. O., Bellman, P., Yangco, B., Lefkowitz, L., Plasse, T. F., & Shepard, K. V. (1995) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(94)00117-4 · Cited by 504
Nagegowda, D. A. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.05.045 · Cited by 404
Cannabinoids for treatment of chronic non‐cancer pain; a systematic review of randomized trials
Lynch, M. E., & Campbell, F. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.03970.x · Cited by 397
Towards the use of cannabinoids as antitumour agents
Velasco, G., Sánchez, C., & Guzmán, M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3247 · Cited by 372
Porter, B. E., & Jacobson, C. (2013) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2013.08.037 · Cited by 359
The biosynthesis of C5–C25 terpenoid compounds
Dewick, P. M. (2002) · Natural Product Reports · doi:10.1039/b002685i · Cited by 357
The Inheritance of Chemical Phenotype in Cannabis sativa L.
de Meijer, E. P. M., Bagatta, M., Carboni, A., Crucitti, P., Moliterni, V. M. C., Ranalli, P., & Mandolino, G. (2003) · Genetics · doi:10.1093/genetics/163.1.335 · Cited by 354
De Petrocellis, L., Vellani, V., Schiano-Moriello, A., Marini, P., Magherini, P. C., Orlando, P., & Di Marzo, V. (2008) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.134809 · Cited by 336
A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain
Wilsey, B., Marcotte, T., Tsodikov, A., Millman, J., Bentley, H., Gouaux, B., & Fishman, S. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.12.010 · Cited by 327
Borrelli, F., Fasolino, I., Romano, B., Capasso, R., Maiello, F., Coppola, D., Orlando, P., Battista, G., Pagano, E., Di Marzo, V., et al. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.01.017 · Cited by 326
Fischedick, J. T., Hazekamp, A., Erkelens, T., Choi, Y. H., & Verpoorte, R. (2010) · Phytochemistry · doi:10.1016/j.phytochem.2010.10.001 · Cited by 325
Cannabis and Cannabis Extracts: Greater Than the Sum of Their Parts?
McPartland, J. M., & Russo, E. B. (2001) · Journal of Cannabis Therapeutics · doi:10.1300/j175v01n03_08 · Cited by 321
Low-Dose Vaporized Cannabis Significantly Improves Neuropathic Pain
Wilsey, B., Marcotte, T., Deutsch, R., Gouaux, B., Sakai, S., & Donaghe, H. (2013) · The Journal of Pain · doi:10.1016/j.jpain.2012.10.009 · Cited by 314
The Gene Controlling Marijuana Psychoactivity
Sirikantaramas, S., Morimoto, S., Shoyama, Y., Ishikawa, Y., Wada, Y., Shoyama, Y., & Taura, F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403693200 · Cited by 271
Muller-Vahl, K. R., Schneider, U., Prevedel, H., Theloe, K., Kolbe, H., Daldrup, T., & Emrich, H. M. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0417 · Cited by 270
A Molecular Link between the Active Component of Marijuana and Alzheimer's Disease Pathology
Eubanks, L. M., Rogers, C. J., Beuscher, Koob, G. F., Olson, A. J., Dickerson, T. J., & Janda, K. D. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060066m · Cited by 268
Treatment of Tourette's Syndrome with Δ9-Tetrahydrocannabinol (THC): A Randomized Crossover Trial
Müller-Vahl, K., Schneider, U., Koblenz, A., Jöbges, M., Kolbe, H., Daldrup, T., & Emrich, H. (2002) · Pharmacopsychiatry · doi:10.1055/s-2002-25028 · Cited by 256
Abrams, D. I., Hilton, J. F., Leiser, R. J., Shade, S. B., Elbeik, T. A., Aweeka, F. T., Benowitz, N. L., Bredt, B. M., Kosel, B., Aberg, J. A., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-4-200308190-00008 · Cited by 238
Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial
Corey-Bloom, J., Wolfson, T., Gamst, A., Jin, S., Marcotte, T. D., Bentley, H., & Gouaux, B. (2012) · Canadian Medical Association Journal · doi:10.1503/cmaj.110837 · Cited by 235
Constituents of Cannabis Sativa
ElSohly, M. A., & Gul, W. (2014) · Handbook of Cannabis · doi:10.1093/acprof:oso/9780199662685.003.0001 · Cited by 220
Herman, T. S., Einhorn, L. H., Jones, S. E., Nagy, C., Chester, A. B., Dean, J. C., Furnas, B., Williams, S. D., Leigh, S. A., Dorr, R. T., et al. (1979) · New England Journal of Medicine · doi:10.1056/nejm197906073002302 · Cited by 216
Cannabidiol: A Promising Drug for Neurodegenerative Disorders?
Iuvone, T., Esposito, G., De Filippis, D., Scuderi, C., & Steardo, L. (2009) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2008.00065.x · Cited by 215
Cannabidiol lowers incidence of diabetes in non-obese diabetic mice
Weiss, L., Zeira, M., Reich, S., Har-Noy, M., Mechoulam, R., Slavin, S., & Gallily, R. (2006) · Autoimmunity · doi:10.1080/08916930500356674 · Cited by 215
De Petrocellis, L., Ligresti, A., Schiano Moriello, A., Iappelli, M., Verde, R., Stott, C. G., Cristino, L., Orlando, P., & Di Marzo, V. (2013) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02027.x · Cited by 210
The Impact of Marijuana Use on Glucose, Insulin, and Insulin Resistance among US Adults
Penner, E. A., Buettner, H., & Mittleman, M. A. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2013.03.002 · Cited by 201
Cannabidiol reduces cigarette consumption in tobacco smokers: Preliminary findings
Morgan, C. J. A., Das, R. K., Joye, A., Curran, H. V., & Kamboj, S. K. (2013) · Addictive Behaviors · doi:10.1016/j.addbeh.2013.03.011 · Cited by 193
Maione, S., Piscitelli, F., Gatta, L., Vita, D., De Petrocellis, L., Palazzo, E., de Novellis, V., & Di Marzo, V. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01063.x · Cited by 175
Izzo, A. A., Capasso, R., Aviello, G., Borrelli, F., Romano, B., Piscitelli, F., Gallo, L., Capasso, F., Orlando, P., & Di Marzo, V. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01879.x · Cited by 168
Aizpurua-Olaizola, O., Omar, J., Navarro, P., Olivares, M., Etxebarria, N., & Usobiaga, A. (2014) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-014-8177-x · Cited by 167
Self-citationPacifico, D., Miselli, F., Carboni, A., Moschella, A., & Mandolino, G. (2008) · Euphytica · doi:10.1007/s10681-007-9543-y · Cited by 147
Alzheimer's disease; taking the edge off with cannabinoids?
Campbell, V. A., & Gowran, A. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707446 · Cited by 137
Brain Cannabinoid Systems as Targets for the Therapy of Neurological Disorders
Consroe, P. F. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0220 · Cited by 133
The inheritance of chemical phenotype in Cannabis sativa L. (II): Cannabigerol predominant plants
de Meijer, E. P. M., & Hammond, K. M. (2005) · Euphytica · doi:10.1007/s10681-005-1164-8 · Cited by 118
Minor oxygenated cannabinoids from high potency Cannabis sativa L.
Ahmed, S. A., Ross, S. A., Slade, D., Radwan, M. M., Khan, I. A., & ElSohly, M. A. (2015) · Phytochemistry · doi:10.1016/j.phytochem.2015.04.007 · Cited by 105
Backer, B. D., Maebe, K., Verstraete, A., & Charlier, C. (2012) · Journal of Forensic Sciences · doi:10.1111/j.1556-4029.2012.02068.x · Cited by 98
The effect of cannabichromene on adult neural stem/progenitor cells
Shinjyo, N., & Marzo, V. D. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.08.002 · Cited by 93
Cannabinoids: Novel Medicines for the Treatment of Huntingtons Disease
Sagredo, O., Pazos, M. R., Valdeolivas, S., & Fernández‐Ruíz, J. (2011) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488912798842278 · Cited by 84
Qualitative and Quantitative Aspects of the Inheritance of Chemical Phenotype inCannabis
Mandolino, G., Bagatta, M., Carboni, A., et al. (2003) · Journal of Industrial Hemp · doi:10.1300/j237v08n02_04 · Cited by 56
A Comparison of the Ocular and Central Effects of Δ 9 -Tetrahydrocannabinol and Cannabigerol
Colasanti, B. K. (1990) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.1990.6.259 · Cited by 53
High Performance Liquid Chromatographic Profiling of Cannabis Products
Lehmann, T., & Brenneisen, R. (1995) · Journal of Liquid Chromatography · doi:10.1080/10826079508009265 · Cited by 47
Meyer, J. S., & Connor, R. E. (1982) · Cancer · doi:10.1002/1097-0142(19820815)50:4<636::aid-cncr2820500404>3.0.co;2-4 · Cited by 41
Cannabinoids as potential new therapy for the treatment of gliomas
Parolaro, D., & Massi, P. (2007) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.1.37 · Cited by 35
Hutcheon, A. W., Palmer, J. B. D., Soukop, M., Cunningham, D., McArdle, C. S., Welsh, J., Stuart, F., Sangster, G., Kaye, S. B., Charlton, D., et al. (1983) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(83)90032-9 · Cited by 30
Cited by
Jin, D., Dai, K., Xie, Z., & Chen, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-60172-6 · Cited by 348
Cannabis glandular trichomes alter morphology and metabolite content during flower maturation
Livingston, S. J., Quilichini, T. D., Booth, J. K., Wong, D. C. J., Rensing, K. H., Laflamme‐Yonkman, J., Castellarin, S. D., Bohlmann, J., Page, J. E., & Samuels, A. L. (2020) · The Plant Journal · doi:10.1111/tpj.14516 · Cited by 309
A new ESI-LC/MS approach for comprehensive metabolic profiling of phytocannabinoids in Cannabis
Berman, P., Futoran, K., Lewitus, G. M., Mukha, D., Benami, M., Shlomi, T., & Meiri, D. (2018) · Scientific Reports · doi:10.1038/s41598-018-32651-4 · Cited by 292
Terpene synthases from Cannabis sativa
Booth, J. K., Page, J. E., & Bohlmann, J. (2017) · PLOS ONE · doi:10.1371/journal.pone.0173911 · Cited by 257
Industrial Hemp: Renewed Opportunities for an Ancient Crop
Fike, J. (2016) · Critical Reviews in Plant Sciences · doi:10.1080/07352689.2016.1257842 · Cited by 254
Metadata
- Authors
- Aizpurua-Olaizola, O., Soydaner, U., Öztürk, E., Schibano, D., Simsir, Y., Navarro, P., Etxebarria, N., & Usobiaga, A.
- Venue
- Journal of Natural Products
- Publisher
- American Chemical Society (ACS)
- Published
- 2016-02-02
- Volume
- 79
- Issue
- 2
- Pages
- 324-331
- ISSN
- 0163-3864 (ISSN-L)
- 1520-6025
- OpenAlex
- W2260109569
- Cited by
- 467
- References
- 54
- FWCI
- 21.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.